David Russ Ramsay files SEC Form 4 disclosures for Vanda Pharmaceuticals Inc.. They have made 17 open-market trades across 3 companies since 2006, most recently 2010-03-12.
CIK 0001352876
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 17 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| VNDA | SELL | 2010-03-12 | 2010-03-15 | $11.80 | $2.4M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-12-14 | 2009-12-16 | $11.09 | $2.5M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-12-08 | 2009-12-10 | $11.52 | $1.5M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-12-04 | 2009-12-08 | $11.64 | $2.3M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2009-10-13 | 2009-10-15 | $12.65 | $3.0M | -4.3% | -1.1% | -1.1% |
| BDSI | SELL | 2009-06-15 | 2009-06-17 | $7.14 | $4.3M | -23.8% | -3.8% | -3.8% |
| ACUR | SELL | 2009-05-22 | 2009-05-27 | $7.42 | $117K | -17.9% | -9.9% | -9.9% |
| ACUR | SELL | 2009-05-06 | 2009-05-08 | $6.79 | $82K | -17.9% | -9.9% | -9.9% |
| VNDA | SELL | 2007-02-23 | 2007-02-27 | $26.02 | $10.0M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2007-02-22 | 2007-02-23 | $26.82 | $1.9M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2007-02-20 | 2007-02-22 | $27.03 | $11.8M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-12-12 | 2006-12-14 | $25.18 | $10.7M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-12-11 | 2006-12-13 | $26.40 | $8.6M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-11-27 | 2006-11-29 | $14.18 | $4.3M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-11-22 | 2006-11-27 | $14.12 | $4.2M | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-11-21 | 2006-11-22 | $14.55 | $728K | -4.3% | -1.1% | -1.1% |
| VNDA | SELL | 2006-11-17 | 2006-11-22 | $14.41 | $4.6M | -4.3% | -1.1% | -1.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.